What is the difference between lumigan and latisse

If you have been diagnosed with glaucoma or ocular hypertension, your doctor or healthcare provider may prescribe Lumigan to help manage your condition.

Latisse comes with an applicator so that you can avoid direct exposure to the eyes. That way you are only targeting the upper eyelids. Because Latisse is only applied on the outer part of the eye, the risk of eye color changes is lower than that of Lumigan.

Because the normal growth cycle of hair takes about 3 to 4 weeks, it may take about one month for you to see visible results. Best results are observed 16 weeks after daily application of Latisse. Again, in terms of results with Latisse versus Lumigan, directly applying either product on your eyes or increasing the dosage does not lead to faster results.

Therefore, you should avoid interchanging the use of each drug. Talk to your healthcare provider about the appropriate administration of Latisse or Lumigan.

Latisse is administered for cosmetic purposes while Lumigan is medically prescribed for patients with eye conditions such as glaucoma and ocular hypertension.

Although they contain the same active ingredient, bimatoprost, both products contain different concentrations of it. Latisse and Lumigan are also applied differently: Latisse is applied to the eyelid area around the base of the eyelashes and Lumigan is applied directly to the eye. But while it is helpful for treating glaucoma, Lumigan may cause a change in the color of the iris, or the part of the eye responsible for the eye color. This can occur as the medication is directly applied to the eye.

Darkening of the eye pigment has usually been observed in patients with natural green or blue eyes. If you are looking for more information about Latisse and guidance on how to use Latisse, you can contact the specialists at Rocky Mountain Skin Care Clinic.

Are Latisse and Lumigan the Same Thing? What is Lumigan? What is Latisse? What is the active ingredient in Latisse vs. Can Lumigan be used for eyelashes? What is the price difference between Latisse and Lumigan?

Also, it is not recommended for pregnant or breastfeeding women. Since this is a prescription drug, Latisse should not be used by anyone other than the person to whom it was prescribed. If you wear contact lenses , take them out before using Latisse. Wait 15 minutes after using the drug before putting your contact lenses back in your eyes. Do not reuse the single-use applicator for this drug or contaminate the bottle by allowing the bottle tip to come into contact with any other surface, as this may lead to serious eye infection.

If you develop a new eye condition, have a sudden decrease in your vision, have eye surgery or develop any eye reactions, immediately call your ophthalmologist. Only an ophthalmologist has the medical training in eye care to assess your particular reactions and conditions.

Find an Ophthalmologist. Advanced Search. Ask an Ophthalmologist. Browse Answers. That changed in the eight-month period during which she participated in a clinical trial to test a drug that glaucoma patients have used for almost a decade to stave off blindness.

Catron has never been diagnosed with glaucoma; instead, she may be among the first to use this drug for its unusual side effect. I never ever, ever had long eyelashes. Allergan, the pharmaceutical company that also manufactures Botox, conducted the trial Catron participated in to test Latisse, a variation of Lumigan, Allergan's glaucoma drug, and its effectiveness as a lash enhancer. The Food and Drug Administration approved Latisse earlier this month.

Scott Whitcup, Allergan's executive vice president of research and development, said researchers at Allergan noted the eyelash-enhancing side effects of Lumigan eye drops during the phase three trials for the drug. Like Lumigan and its active ingredient bimatoprost, many medicines or medical treatments can get a second life if their side effects are found practical, useful or desirable.

Botox, a paralytic agent, was originally approved by the FDA in to treat nerve spasms, particularly around the eye, which caused crossed eyes or uncontrollable blinking. But users discovered their skin showed fewer wrinkles after the injections and the FDA approved Botox for cosmetic use in Known as "the Barbie pill," Melanotan II was supposed to be a body-trimming wonder drug that killed appetite and increased libido.

The drug was initially developed to combat skin cancer by increasing levels of melanin, the skin pigments that naturally protect the body from sunlight. But some users reported more freckling and darker moles after use, a potential problem for those who may have been trying to monitor their skin for signs of cancer. The drug was never studied thoroughly.